Company Filing History:
Years Active: 2018
Title: Innovations of Hoa Thu Ngo in Antibody Development
Introduction
Hoa Thu Ngo is an accomplished inventor based in Leuven, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. His work focuses on innovative solutions for treating various diseases, including cancer.
Latest Patents
Hoa Thu Ngo holds a patent for "Anti-PDGF-C antibodies." This invention relates to antibodies that bind to the PDGF-C antigen. These antibodies are capable of inhibiting the binding of PDGF-C to the PDGFRα receptor and preventing PDGFRα activation by PDGF-C. The applications of these antibodies include potential treatments for cancer, showcasing their importance in medical research and therapy.
Career Highlights
Hoa Thu Ngo is associated with Thrombogenics NV, a company known for its focus on innovative therapies. His work at the company has been pivotal in advancing research in the field of antibodies and their applications in medicine. His dedication to innovation has positioned him as a key figure in the biotechnology sector.
Collaborations
Hoa Thu Ngo collaborates with notable colleagues, including Claudia Fromond and Richard Reinier Zwaal. These collaborations enhance the research environment and contribute to the development of groundbreaking therapies.
Conclusion
Hoa Thu Ngo's contributions to antibody development represent a significant advancement in the fight against cancer. His innovative work continues to inspire and pave the way for future research in biotechnology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.